Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of obesity. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://sidneysveo226192.dsiblogger.com/71929690/trelaglutide-exploring-a-new-therapy-for-chronic-diseases